"Health" agrees with American company to treat children infected with "C" virus

Salif Sau, vice president of the US drug-producing company Covaldi, said that his company had recently signed a memorandum of understanding with the Egyptian Ministry of Health to provide new treatment to patients with dementia. viral hepatitis C, to children and adolescents, as well as to adults who do not respond to currently available treatments.

The vice president of the US company, responsible for developing emerging markets in Africa, told "Egyptian Today" that this new treatment was to take one capsule a day for 12 weeks, noting that the new drug was achieving response rates ranging up to 98% in patients with HIV. "C" of all genotypes.

He added: "This milestone is the latest in ongoing cooperation between the US society and the Egyptian government to provide access to virus treatments, where up to now more than one million people in Egypt were treated with direct-impact antivirals. "

Dr. Mohamed Hbadani, Deputy Minister of Health for Health Initiatives and Director of the National Campaign for the Elimination of Virus C, announced the discovery of 20,000 children at the preparatory and secondary stages of "C virus", after reviewing 7 million students, as part of the initiative '100 million Health.

He said "Hbadani" that for the first time in this category he pointed out that early infection with hepatitis speeds up the onset of complications and symptoms, pointing out that the initiative is targeting the preparatory clbad next year because last year's survey did not include elementary school students.

Dr. Mbad Hamdy El-Sayed, a member of the National Committee for the Control of Hepatitis Viruses, said that Egypt is the first country in the world to implement a therapeutic program that includes screening and treatment children. As a result, the students were not informed of their injuries and the ministry only reported their families.